List of psoriasis concept stocks
1. Fosun Pharma (600 196), a subsidiary of Shanghai Fuhong Hanlin Biotechnology Co., Ltd., has been included in the priority review procedure. The indication of this new drug for the treatment of plaque psoriasis is in clinical phase III trial in China. By the end of 2065438+March 2009, the Group had invested about RMB 208.59 million (unaudited) in the research and development of this new drug (including indications for treating psoriasis plaque and rheumatoid arthritis).
2. Yifan Pharmaceutical Co., Ltd. (0020 19), a wholly-owned subsidiary of Sichuan Defeng Pharmaceutical Co., Ltd., submitted its application for clinical trial of tazatassol ointment project to the State Pharmaceutical Product Supervision and Administration on 2010/9, and was accepted. Tazatasol ointment is an improved new drug that has not been marketed at home and abroad. It is a compound ointment, which is intended to be used to treat psoriasis vulgaris in clinic.
3. Heiske (002653), a calcipotriol betamethasone ointment declared by the company, is used to treat patients with plaque psoriasis aged 18 years and above.
4. Haizheng Pharmaceutical Co., Ltd. (600267) and the Drug Evaluation Center of the State Administration of Pharmaceutical Products accepted the application for registration of adalimumab injection drugs submitted by the company. This product belongs to anti-tumor tumor tumor necrosis factor (TNF) biological preparation, which can treat corresponding diseases by neutralizing the biological activity of TNF-α in vivo. Applicable indications are ankylosing spondylitis, rheumatoid arthritis and plaque psoriasis.
5. Guizhou Bailing (002424), the company holds Chengdu Yuling Biomedical Technology, and its main project is "Targeting small molecule drugs to treat autoimmune diseases" to directly treat psoriasis.
6. Winbond Health (002004), the company's main product, carbotriol ointment, is suitable for local treatment of psoriasis vulgaris; Halometasone cream is suitable for coin dermatitis and psoriasis vulgaris; Aviva capsule is suitable for severe psoriasis, including erythrodermic psoriasis, pustular psoriasis and other keratinized skin diseases.
7. Guan Hao Bio (300238), the holding subsidiaries of Guan Hao Bio, Jingwenfeng and Zhonghao Pharmaceutical, owns the patent and intellectual property rights of Tapinarov (* * nematode) in * * * area, and its products are mainly used to treat psoriasis.